Cihan Erol, Abdullah Sakin, Tuğba Başoğlu, Ercan Özden, Devrim Çabuk, Mutlu Doğan, Berna Öksüzoğlu, Hasan Çağrı Yıldırım, İrem Öner, Melek Karakurt Eryılmaz, Özgecan Dülgar, Dinçer Aydın, Neslihan Doğan, Miraç Özen, İlhan Hacıbekiroğlu, Nuriye Özdemir, Fatih Gürler, Nail Paksoy, Senem Karabulut, Asude Aksoy, Mutlu Hızal, Seda Kahraman, Erdem Şen, Semra Paydaş, Ebru Çılbır, Feyza Fırat, Nadiye Akdeniz, Melike Özçelik, Abdilkerim Oyman, Naziyet Köse Baytemür, Ramazan Acar, Elvina Almuradova, Bülent Karabulut, Teoman Şakalar, Hacı Arak, Ezgi Değerli, Sema Türker, Özkan Alan, Özlem Er, Elif Şenocak Taşçı, Nazan Demir, Eyyüp Çavdar, Serdar Turhal, Didem Şener Dede, Muhammed Bülent Akıncı, Bülent Yalçın, Fulden Yumuk, Şuayib Yalçın, Mehmet Ali Nahit Şendur
BACKGROUND: Perioperative FLOT regimen is a standard of care in locally advanced operable gastric and GEJ adenocarcinoma. We aimed to determine the efficacy, prognostic factors of perioperative FLOT chemotherapy in real-life gastric and GEJ tumors. METHODS: The data of patients who were treated with perioperative FLOT chemotherapy were retrospectively analyzed from 34 different oncology centers in Turkey. Baseline clinical and demographic characteristics, pretreatment laboratory values, histological and molecular characteristics were recorded...
August 2022: Turkish Journal of Medical Sciences